HHS and ARPA-H launched SPECTRA to improve autism diagnosis with objective measurement tools.
Why it matters: The program is aimed at making autism assessment less dependent on behavioral observation alone. It is part of a broader federal autism package that also includes research, care access and alert initiatives.
- HHS Secretary Robert F. Kennedy Jr. announced ARPA-H's SPECTRA program on Sept. 17, 2026.
- ARPA-H says SPECTRA will emphasize objective, multi-factor measurement and computation over behavioral observation alone.
- HHS said the broader package includes leucovorin-related actions, NIH Autism Data Science Initiative recipient announcements, HRSA workforce and access-to-care steps and a missing-and-endangered person alert initiative.
- CDC surveillance cited by HHS shows autism prevalence at 1 in 31 U.S. children born in 2014.
HHS Secretary Robert F. Kennedy Jr. announced ARPA-H's SPECTRA program on Sept. 17, 2026. HHS said the effort is meant to speed autism diagnosis and what it calls precision care.
ARPA-H describes SPECTRA as a push to move beyond behavioral observation alone and use objective, multi-factor measurement and computation. The agency says current diagnosis and treatment can be costly, time-intensive and constrained by specialist availability. Its solicitation asks for proposals in four areas: analysis, modeling, precision intervention and enabling technologies. More detail is on the ARPA-H SPECTRA page.
STAT reported Kennedy unveiled the initiative during a keynote at a Children’s Health Defense conference, the anti-vaccine organization he previously led. AP reported he told activists they have a friend in Trump’s White House.
HHS said SPECTRA is one part of a wider autism package. The department said that package also includes leucovorin-related actions, which refer to federal steps involving the folinic-acid drug leucovorin, NIH Autism Data Science Initiative recipient announcements, HRSA workforce and access-to-care steps, and a federal autism missing-and-endangered person alert initiative.
HHS cited CDC surveillance showing autism prevalence of 1 in 31 U.S. children born in 2014. The public materials do not say how much money SPECTRA will receive or how many awards ARPA-H expects to make.
By the numbers
- 1 in 31 - autism prevalence among U.S. children born in 2014, according to CDC surveillance cited by HHS
- Sept. 17, 2026 - date HHS announced ARPA-H's SPECTRA program
Yes, but: HHS has not said how much funding SPECTRA will get or how many awards ARPA-H expects to make.